Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induced pluripotent stem cells derived from an autosomal dominant lateral temporal epilepsy (ADLTE) patient carrying S473L mutation in leucine-rich glioma inactivated 1 (LGI1).
Tan GW, Kondo T, Murakami N, Imamura K, Enami T, Tsukita K, Shibukawa R, Funayama M, Matsumoto R, Ikeda A, Takahashi R, Inoue H. Tan GW, et al. Among authors: shibukawa r. Stem Cell Res. 2017 Oct;24:12-15. doi: 10.1016/j.scr.2017.07.030. Epub 2017 Jul 29. Stem Cell Res. 2017. PMID: 29034879 Free article.
Modeling Drug-Induced Neuropathy Using Human iPSCs for Predictive Toxicology.
Ohara R, Imamura K, Morii F, Egawa N, Tsukita K, Enami T, Shibukawa R, Mizuno T, Nakagawa M, Inoue H. Ohara R, et al. Among authors: shibukawa r. Clin Pharmacol Ther. 2017 Jun;101(6):754-762. doi: 10.1002/cpt.562. Epub 2017 Jan 11. Clin Pharmacol Ther. 2017. PMID: 27859025
Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene.
Sekine SI, Kondo T, Murakami N, Imamura K, Enami T, Shibukawa R, Tsukita K, Funayama M, Inden M, Kurita H, Hozumi I, Inoue H. Sekine SI, et al. Among authors: shibukawa r. Stem Cell Res. 2017 Oct;24:40-43. doi: 10.1016/j.scr.2017.07.028. Epub 2017 Jul 29. Stem Cell Res. 2017. PMID: 29034894 Free article.
Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I.
Suga M, Kondo T, Imamura K, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, Enami T, Furujo M, Saijo K, Nakamura Y, Osawa M, Saito MK, Yamanaka S, Inoue H. Suga M, et al. Among authors: shibukawa r. Stem Cell Res. 2019 Apr;36:101406. doi: 10.1016/j.scr.2019.101406. Epub 2019 Feb 12. Stem Cell Res. 2019. PMID: 30849633 Free article.
Generation of a human induced pluripotent stem cell line, BRCi005-A, derived from a Best disease patient with BEST1 mutations.
Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, Yasukawa T, Usui H, Muguruma K, Tsujikawa A, Inoue H. Kamata K, et al. Among authors: shibukawa r. Stem Cell Res. 2020 May;45:101782. doi: 10.1016/j.scr.2020.101782. Epub 2020 Apr 29. Stem Cell Res. 2020. PMID: 32416576 Free article.
Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degeneration.
Kamata K, Otsuka Y, Imamura K, Oishi A, Kondo T, Suga M, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, Yasukawa T, Usui H, Muguruma K, Tsujikawa A, Inoue H. Kamata K, et al. Among authors: shibukawa r. Stem Cell Res. 2020 May;45:101787. doi: 10.1016/j.scr.2020.101787. Epub 2020 Apr 21. Stem Cell Res. 2020. PMID: 32416577 Free article.
19 results